Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Operations (Unaudited)

v3.10.0.1
Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
3 Months Ended 9 Months Ended
Sep. 30, 2018
Sep. 30, 2017
Mar. 31, 2017
Sep. 30, 2018
Sep. 30, 2018
Sep. 30, 2017
Income Statement [Abstract]            
NET REVENUE $ 17,044,526 $ 7,513,592   $ 34,034,788   $ 23,518,416
OPERATING EXPENSES:            
Direct operating costs 12,123,907 4,171,932   20,941,535   13,592,492
Selling and marketing 461,512 228,991   1,169,583   853,460
General and administrative 5,131,295 2,474,139   10,786,234   8,232,613
Research and development 263,717 249,045   768,517   843,294
Change in contingent consideration 25,473   68,253   151,423
Depreciation and amortization 822,098 664,441   1,972,565   3,637,131
Restructuring charges $ 276,000   275,628
Total operating expenses 18,828,002 7,788,548   35,706,687   27,586,041
OPERATING LOSS (1,783,476) (274,956)   (1,671,899)   (4,067,625)
OTHER:            
Interest income 24,544 5,446   59,768   13,598
Interest expense (104,872) (678,103)   (253,120)   (1,242,672)
Other (expense) income - net (218,721) 32,494   151,242   107,364
LOSS BEFORE INCOME TAXES (2,082,525) (915,119)   (1,714,009)   (5,189,335)
Income tax (benefit) provision (250,072) 65,000   (151,872)   192,332
NET LOSS (1,832,453) (980,119)   (1,562,137) $ (1,562,137) (5,381,667)
Preferred stock dividend 1,056,214 652,697   3,080,263   1,283,151
NET LOSS ATTRIBUTABLE TO COMMON SHAREHOLDERS $ (2,888,667) $ (1,632,816)   $ (4,642,400)   $ (6,664,818)
Net loss per common share: basic and diluted $ (0.25) $ (0.14)   $ (0.40)   $ (0.62)
Weighted-average common shares used to compute basic and diluted loss per share 11,770,178 11,485,811   11,684,659   10,835,142